Official Title:A randomised, double blind, placebo controlled study to evaluate the micro-macroscopic effects on muscles, the safety and tolerability, and the efficacy of Givinostat in patients with Becker Muscular Dystrophy (DSC/14/2357/53).
Purpose: The main objective of the study was to evaluate whether the beneficial histological effects observed with Givinostat in the DMD patients could be extended to Becker patients.
Location: Europe (Italy and the Netherland).
For more information and enrollment status, please visit www.clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT03238235) or https://www.clinicaltrialsregister.eu/ctr-search/search.